A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA

Clinical trial NCT05601128 · COMPLETED

Trial details

NCT number: NCT05601128
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

HIV-1-infection HIV Infections HIV I Infection

Start date: 2023-01-01
Primary completion: 2025-04-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.